当前位置: X-MOL 学术Bipolar Disord. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacological management of bipolar disorder: Japanese expert consensus.
Bipolar Disorders ( IF 5.4 ) Pub Date : 2020-06-17 , DOI: 10.1111/bdi.12959
Hitoshi Sakurai 1, 2 , Masaki Kato 3 , Norio Yasui-Furukori 4 , Takefumi Suzuki 5 , Hajime Baba 6 , Koichiro Watanabe 7 , Ken Inada 8 , Ikuko Kishida 9, 10 , Yuka Sugawara Kikuchi 11 , Toshiaki Kikuchi 2 , Asuka Katsuki 12 , Hiroyuki Uchida 2 ,
Affiliation  

The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP‐I and BP‐II), in order to fill the gap in the literature and provide more concrete guidance for challenging and controversial real‐world situations.

中文翻译:

躁郁症的药理管理:日本专家共识。

这项研究的目的是,由日本临床神经心理药物学会的认证专家制定一项针对双相情感障碍I和II(BP-I和BP-II)的心理药物治疗的共识性指南,以填补文献中的空白。并为具有挑战性和争议性的现实情况提供更具体的指导。
更新日期:2020-06-17
down
wechat
bug